Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
University of California, Los Angeles · Weill Cornell Medicine · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,086
total citations
- FWCI
- 51.26
- Percentile
- 100%
- References
- 32
Citations per year
Authors
8Topics & keywords
Topics
Keywords
- Medicine
- Pembrolizumab
- Common Terminology Criteria for Adverse Events
- Pneumonitis
- Internal medicine
- Lung cancer
- Radiation therapy
- Discontinuation
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.